Marc L. Melcher

Clinical Focus

• General Surgery
• Liver Transplantation
• Kidney Transplantation
• Hepatobiliary

Administrative Appointments

• Program Director, Stanford Surgery Residency (2011 - present)
• Associate Program Director, Stanford Multi-Organ Transplant Fellowship (2010 - present)
• Associate Program Director, Stanford Surgery Residency (2006 - 2011)
• Administrative Chief Resident, Stanford Surgery Residency (2003 - 2004)

Honors and Awards

• Member, Pacific Coast Surgical Society (2012 -)
• Poster of Distinction, American Transplant Congress (2010)
• Member, San Francisco Surgical Society (2009-)
• Member, American Society of Transplant Surgeons (2004-)
• Fellow, American College of Surgeons (2009 -)

Professional Education

Community and International Work

• International Medicine, Guatemala 

Internet Links

• Paired Exchange Kidney Donation

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information

Current Research Interests

My goal is to extend the benefits of organ transplant to greater numbers of patients while maintaining Stanford's excellent outcomes. We have set up a protocol to treat morbidly obese patients, who normally would not qualify for kidney transplant, with bariatric surgery prior to kidney transplantation. We are also developing the "paired-organ exchange" program at Stanford to increase the chances that patients with willing but incompatible living donors can still receive a living donor kidney.

Clinical Trials

• Combined Blood Stem Cell and HLA Haplotype Match Living Donor Kidney Transplantation Recruiting
• An Investigational Plan Evaluating the Operative Management of Parenchymal Bleeding by Means of an Adjunctive Application of BioFoam® Surgical Matrix in Liver Surgery Not yet recruiting

Publications

• Cytomegalovirus in the transplanted kidney: a report of two cases and review of prophylaxis Anand S, Yabu JM, Melcher ML, Kambham N, Laszik Z, Tan JC.. Nephrology Dialysis Transplantation. 2011; 4 (5): 342-345
• Incidental kidney stones: a single center experience with kidney donor selection. Kim IK, Tan JC, Lapasia J, Elihu A, Busque S, Melcher ML. Clin Transplant. 2011
• Managing finances of shipping living donor kidneys for donor exchanges. Mast DA, Vaughan W, Busque S, Veale JL, Roberts JP, Straube BM, Flores N, Canari C, Levy E, Tietjen A, Hil G, Melcher ML. Am J Transplant. 2011; 11 (9): 1810-4
• Potential nutritional conflicts in bariatric and renal transplant patients. Lightner AL, Lau J, Obayashi P, Birge K, Melcher ML. Obes Surg. 2011; 21 (12): 1965-70
• Sclerosing peritonitis after kidney transplantation: a not-so-silky cocoon. Morrow EH, Gallo AE, Melcher ML. Dig Dis Sci. 2011; 56 (2): 307-10